Literature DB >> 10810635

Ribozymes. Their design and use in cancer.

P C Turner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10810635     DOI： 10.1007/0-306-46817-4_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  2 in total

1.  The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells.

Authors:  Darby L Thomas; Martin Lock; Janice M Zabolotny; Bangalore R Mohan; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  pcDNA3.1(-)-mediated ribozyme targeting of HER-2 suppresses breast cancer tumor growth.

Authors:  Pei He; Dan Zhu; Jun-Jian Hu; Ju Peng; Lian-Sheng Chen; Guang-Xiu Lu
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.